MedPath

Comparison of Pantomiming and Easy Onset Treatment

Not Applicable
Conditions
Stammering
Interventions
Other: Easy onset
Other: Pantomiming
Registration Number
NCT04813588
Lead Sponsor
Riphah International University
Brief Summary

This research will give in-depth understanding of pantomiming and easy onset method as an intervention of stuttering and especially blocking. And by comparing both methods, It will also determine that which method is more effective. This research will also improve the overall awareness regarding stuttering

Detailed Description

Research participants will be divided into two groups through randomization, Group A \& Group B. Base line assessment will be conducted. Intervention will be provided (thrice a week on alternative days).post assessment will be taken and data will be analyzed through SPSS.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Participants falling in this category would be added into the study.
  • School aged children and adolescents ages between 6 to 18 years(both genders) who stutter with blocking symptoms
  • Participant who will be at moderate level of stammering will be included
Read More
Exclusion Criteria
  • Participant failing to fall in this category would be excluded of the study.
  • Participants with any other medical condition will be excluded
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Easy onsetEasy onsetIn active comparator group easy onset method will be administered
PantomimngPantomimingIn experimental group pantomiming treatment will be administered
Primary Outcome Measures
NameTimeMethod
The real time analysis12 weeks

Changes from base line "The Real time analysis will use. It will use to assessed the changes in frequency ,duration types and severity of disfluencies in spontaneous speech.The total number of dysfluencies will be divided by the total number of syllables then multiply answer by 100 .Results between 2% showed normal range,8-15% will consider Moderate level, 12% will consider as severe level

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Maryam Nadir Kiyani

🇵🇰

Rawalpindi, Punjab, Pakistan

© Copyright 2025. All Rights Reserved by MedPath